← SynDRA
ILOPERIDONE
SynDRA canonical compound SYN0000751 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | HTR7 |
|---|
| Mechanism of action | Serotonin receptor antagonist |
|---|
| Indication | schizophrenia |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- HTR2A
- DRD2
- HTR7
- HTR6
- HTR1A
- ADRA1A
- DRD1
- DRD4
- DRD3
- HRH1
- ADRA2C
- CHRM4
Mechanisms of action (all sources)
- Dopamine receptor antagonist
- Serotonin receptor antagonist
- DRD2 ANTAGONIST
- Dopamine D2 receptor antagonist
- HTR2A ANTAGONIST
- Serotonin 2a (5-HT2a) receptor antagonist
- HTR1A ANTAGONIST
- HTR6 ANTAGONIST
- HTR7 ANTAGONIST
Drug classes
- Atypical Antipsychotic
- Antipsychotic Agents
- Central Nervous System Agents
- Central Nervous System Depressants
- Psychotropic Drugs
- Tranquilizing Agents
ATC classes
Cross-references
Synonyms
- HP 873
- zomaril
- fanapt
- Iloperidona
- HP-873
- Fanapt
- Fanapta
- Fiapta
- Zomaril
- Fanapt (TN)
- ILO-522
- Iloperidone [USAN:INN]
- Fanapta, Zomaril, Iloperidone
- Iloperidone (USAN/INN)
- 1-[4-[3-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]propoxy]-3-methoxyphenyl]ethanone
- 4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone
- VPO7KJ050N
- iloperidone (usp-rs)
- iloperidona
- iloperidonum
- DTXCID7028986
- CHEBI:65173
- RefChem:55393
- N05AX14
- Iloperidone (Fanapt)
- C24H27FN2O4
- Iloperidone-d3
- MFCD00866688
- s1483
- NCGC00188864-01
- SMR002529575
- CAS-133454-47-4
- UNII-VPO7KJ050N
- Iloperidone [USAN:INN:BAN]
- HSDB 8207
- HP873
- PS36 - Iloperidone
- ILOPERIDONE [MI]
Reported adverse events
- Agranulocytosis
- Akathisia
- Arthralgia
- Bradykinesia
- Dizziness
- Dyskinesia
- Dystonia
- Fatigue
- Hypotension
- Lethargy
- Leukopenia
- Nasopharyngitis
Look up ILOPERIDONE in the interactive SynDRA portal →